NYSE - Delayed Quote USD

Inspire Medical Systems, Inc. (INSP)

Compare
169.99
-5.44
(-3.10%)
At close: 4:00:02 PM EST
167.50
-2.49
(-1.46%)
After hours: 5:20:02 PM EST
Loading Chart for INSP
DELL
  • Previous Close 175.43
  • Open 176.84
  • Bid 167.50 x 900
  • Ask 179.10 x 800
  • Day's Range 168.74 - 179.95
  • 52 Week Range 123.00 - 257.40
  • Volume 728,103
  • Avg. Volume 527,054
  • Market Cap (intraday) 5.094B
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) 153.14
  • EPS (TTM) 1.11
  • Earnings Date Feb 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 239.60

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

www.inspiresleep.com

1,011

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INSP

View More

Performance Overview: INSP

Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

INSP
7.94%
S&P 500
1.08%

1-Year Return

INSP
8.54%
S&P 500
22.14%

3-Year Return

INSP
27.83%
S&P 500
25.41%

5-Year Return

INSP
113.21%
S&P 500
77.70%

Compare To: INSP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INSP

View More

Valuation Measures

Annual
As of 1/13/2025
  • Market Cap

    5.26B

  • Enterprise Value

    4.87B

  • Trailing P/E

    158.05

  • Forward P/E

    93.46

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.04

  • Price/Book (mrq)

    7.55

  • Enterprise Value/Revenue

    6.45

  • Enterprise Value/EBITDA

    125.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.37%

  • Return on Assets (ttm)

    1.17%

  • Return on Equity (ttm)

    5.33%

  • Revenue (ttm)

    755.59M

  • Net Income Avi to Common (ttm)

    33.05M

  • Diluted EPS (ttm)

    1.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    410.99M

  • Total Debt/Equity (mrq)

    3.64%

  • Levered Free Cash Flow (ttm)

    21.27M

Research Analysis: INSP

View More

Company Insights: INSP

Research Reports: INSP

View More

People Also Watch